Načítá se...
Prospects for a MERS-CoV spike vaccine
INTRODUCTION: Six years have passed since Middle East respiratory syndrome (MERS) coronavirus (MERS-CoV), a newly emerging infectious virus, was first reported in 2012. Although MERS-CoV has had a consistently high mortality rate in humans, no vaccines have been approved to prevent MERS-CoV infectio...
Uloženo v:
| Vydáno v: | Expert Rev Vaccines |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6355461/ https://ncbi.nlm.nih.gov/pubmed/30058403 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14760584.2018.1506702 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|